Navigation Links
Novel technique could help boost IVF success and reduce multiple pregnancies
Date:1/3/2012

A new technique successfully used in mice to identify embryos likely to result in a successful pregnancy could be used in humans, potentially boosting IVF success rates and helping to reduce the number of multiple births (1), according to Cardiff University scientists.

The findings, published in the international journal, Fertility and Sterility and funded by the Wellcome Trust, used an advanced imaging technique to track the discrete movements inside an egg that occur during stimulation at fertilization.

The Cardiff scientists worked with a team in Oxford University to analyse the internal contents of the human egg or cytoplasm to observe distinct rhythmic patterns.

"Current IVF treatment involves fertilising eggs in the laboratory and then choosing those embryos considered to be the healthiest for implantation into the mother's womb, using selection criteria such as the number and appearance of cells produced during the division process," according to Professor Karl Swann from Cardiff University's School of Medicine, who led the research.

"However, the implantation of selected eggs using current methods requires days in culture and does not always succeed."

"We already know from previous research in mice that sperm entry into the mouse egg triggers "rhythmic cytoplasmic motions", which may help to predict successful embryo development. Adopting this key method we have now been able to show that the same type of rhythmic movements occur in human eggs," he added.

Eggs that had failed to fertilise following IVF treatment were donated by patients attending the IVF Wales clinic, the fertility unit at Cardiff's University Hospital of Wales. In a HFEA-approved procedure, the eggs were injected with an egg-activating sperm-specific protein ('PLC-zeta') and then imaged over a period of several hours.

The scientists were able to view distinct internal movements or spasms which is the first time that they have been detected in human eggs These movements correlate exquisitely with the exact timing of biochemical changes occurring at fertilisation. The scientists hope that this information could help provide an early and effective indication of viability of a successful pregnancy in human IVF.

Professor Swann added: "Previous analysis of mouse fertilisation have suggested that using this technique may provide an early and effective indication of a successful pregnancy after IVF. We have now discovered that this method has the potential to be applied to human eggs.

"There is a still a great deal of additional research to confirm whether these movements directly correlate with positive pregnancy but this technique holds the promise of predicting the best embryo for IVF which should help cut down multiple pregnancies that often occurs during IVF treatment as a result of transferring several embryos at a time."


'/>"/>
Contact: Professor Karl Swann
Swannk1@cardiff.ac.uk
44-207-42039
Cardiff University
Source:Eurekalert

Related medicine news :

1. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
2. A novel in vitro model for light-induced wound healing
3. Novel program translates behavioral and social science research into treatments to reduce obesity
4. Reovirus may be a novel approach to prostate cancer treatment
5. Novel stroke treatment passes safety stage of UCI-led clinical trial
6. Novel medical home program for pediatric patients, families cuts ER visits in half
7. MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010
8. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
9. Novel Method Eyed for Normalizing Blood Sugar
10. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
11. Novel nanoparticles prevent radiation damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... PR ... an upcoming case studies guidebook. This guidebook offers an excellent branding and exposure ... include articles, case studies and how-to’s that fall into the following categories:, ...
(Date:6/27/2017)... ... , ... Dr. Richard Amato, a respected periodontist in Monroe, CT, ... Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added two ... to improve patient comfort while making it possible for Dr. Amato to provide even ...
(Date:6/27/2017)... North Hollywood, CA (PRWEB) , ... June 27, ... ... on orthodontic treatments . Orthodontics is a dental specialty that focuses on ... other appliances. Benefits include improved aesthetics and function. , North Hollywood ...
(Date:6/26/2017)... ... June 26, 2017 , ... Torrance dentist, Dr. Robert ... be one of the most noticeable aspects of a person’s appearance. A healthy, radiant ... is born with beautiful, balanced teeth, everyone can have the smile of their dreams ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced ... hiring of Richard Robinson as chief operating officer (COO). In this role, Robinson ... proven track record of simplifying business processes and developing growth strategies to increase ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: